Furthermore, increased IL-21R levels have been reported in patients with rheumatoid arthritis, systemic sclerosis, and inflammatory bowel disease, including Crohn's disease and ulcerative colitis (39, 54–56). This evidence concerns the gene IL21R and systemic sclerosis.